https://business-news.org/article/36607-center-for-scientific-review-notice-of-closed-meetings2026-10-17T19:30:55.048Z0.6https://business-news.org/ar/article/36607-2026-10-17T19:30:55.048Z0.5https://business-news.org/de/article/36607-schlussmitteilung-der-wissenschaftlichen-bewertungskommission2026-10-17T19:30:55.048Z0.5https://business-news.org/es/article/36607-el-centro-de-revision-cientifica-emite-un-aviso-sobre-reuniones-cerradas2026-10-17T19:30:55.048Z0.5https://business-news.org/fr/article/36607-notice-de-reunions-fermees-de-la-centre-pour-la-revue-scientifique2026-10-17T19:30:55.048Z0.5https://business-news.org/it/article/36607-nota-di-chiusura-di-riunioni-centro-per-la-revisione-scientifica2026-10-17T19:30:55.048Z0.5https://business-news.org/ja/article/36607-2026-10-17T19:30:55.048Z0.5https://business-news.org/ko/article/36607-2026-10-17T19:30:55.048Z0.5https://business-news.org/nl/article/36607-verklaring-van-gesloten-bijeenkomsten-van-het-center-voor-wetenschappelijk-onderzoek2026-10-17T19:30:55.048Z0.5https://business-news.org/pl/article/36607-osrodek-badan-naukowych-postanowienie-o-zamknietych-sesjach2026-10-17T19:30:55.048Z0.5https://business-news.org/pt/article/36607-aviso-de-reunioes-fechadas-do-centro-de-revisao-cientifica2026-10-17T19:30:55.048Z0.5https://business-news.org/ru/article/36607-2026-10-17T19:30:55.048Z0.5https://business-news.org/tr/article/36607-bilimsel-yurutme-merkezi-kapat-lm-s-toplant-lar-hakk-nda-bilgilendirme2026-10-17T19:30:55.048Z0.5https://business-news.org/uk/article/36607-2026-10-17T19:30:55.048Z0.5https://business-news.org/zh/article/36607-2026-10-17T19:30:55.048Z0.5https://business-news.org/article/36653-center-for-scientific-review-amended-notice-of-meeting2026-10-18T01:40:19.980Z0.6https://business-news.org/ar/article/36653-2026-10-18T01:40:19.980Z0.5https://business-news.org/de/article/36653-anderung-der-sitzungseinladung-des-center-for-scientific-review2026-10-18T01:40:19.980Z0.5https://business-news.org/es/article/36653-revision-cientifica-aviso-modificado-de-reunion2026-10-18T01:40:19.980Z0.5https://business-news.org/fr/article/36653-mise-a-jour-de-la-convocation-du-centre-de-revision-scientifique2026-10-18T01:40:19.980Z0.5https://business-news.org/it/article/36653-nota-di-modifica-della-riunione-del-centro-per-la-revisione-scientifica2026-10-18T01:40:19.980Z0.5https://business-news.org/ja/article/36653-center-for-scientific-review2026-10-18T01:40:19.980Z0.5https://business-news.org/ko/article/36653-2026-10-18T01:40:19.980Z0.5https://business-news.org/nl/article/36653-aangepast-notitie-van-vergadering-van-het-centrum-voor-wetenschappelijk-onderzoek2026-10-18T01:40:19.980Z0.5https://business-news.org/pl/article/36653-zmieniona-oznaczenie-spotkania-centrum-przegladu-naukowego2026-10-18T01:40:19.980Z0.5https://business-news.org/pt/article/36653-revisao-cientifica-aviso-de-reuniao-ajustado2026-10-18T01:40:19.980Z0.5https://business-news.org/ru/article/36653-2026-10-18T01:40:19.980Z0.5https://business-news.org/tr/article/36653-bilimsel-yurutme-merkezi-nin-toplant-bildirisi2026-10-18T01:40:19.980Z0.5https://business-news.org/uk/article/36653-2026-10-18T01:40:19.980Z0.5https://business-news.org/zh/article/36653-2026-10-18T01:40:19.980Z0.5https://business-news.org/article/36662-agency-forms-undergoing-paperwork-reduction-act-review2026-10-18T01:59:42.172Z0.6https://business-news.org/ar/article/36662-2026-10-18T01:59:42.172Z0.5https://business-news.org/de/article/36662-behordenformulare-unterliegen-der-uberprufung-des-papierverarbeitungsreduktionsgesetzes2026-10-18T01:59:42.172Z0.5https://business-news.org/es/article/36662-las-agencias-estan-sometidas-a-una-revision-del-acto-de-reduccion-de-papeleo-administrativ2026-10-18T01:59:42.172Z0.5https://business-news.org/fr/article/36662-les-formulaires-d-agence-sont-soumis-a-une-revision-de-la-loi-sur-la-reduction-des-formali2026-10-18T01:59:42.172Z0.5https://business-news.org/it/article/36662-le-forme-dell-agenzia-sono-oggetto-di-revisione-del-decreto-di-riduzione-dei-documenti2026-10-18T01:59:42.172Z0.5https://business-news.org/ja/article/36662-2026-10-18T01:59:42.172Z0.5https://business-news.org/ko/article/36662-2026-10-18T01:59:42.172Z0.5https://business-news.org/nl/article/36662-organisaties-ondergaan-onderzoek-naar-wet-tot-verlichting-van-papierwerk2026-10-18T01:59:42.172Z0.5https://business-news.org/pl/article/36662-agencja-wprowadza-zmiany-w-zwiazku-z-aktem-redukcji-paperwork-w-procesie-przetwarzania2026-10-18T01:59:42.172Z0.5https://business-news.org/pt/article/36662-agencia-submete-formularios-a-revisao-da-lei-de-reducao-de-papel-de-trabalho2026-10-18T01:59:42.172Z0.5https://business-news.org/ru/article/36662-2026-10-18T01:59:42.172Z0.5https://business-news.org/tr/article/36662-bilgi-veri-azaltma-yasas-uygulamas-dair-duzenleme-komisyonu-taraf-ndan-denetlenmekte-olan-2026-10-18T01:59:42.172Z0.5https://business-news.org/uk/article/36662-2026-10-18T01:59:42.172Z0.5https://business-news.org/zh/article/36662-2026-10-18T01:59:42.172Z0.5https://business-news.org/article/36663-proposed-data-collection-submitted-for-public-comment-and-recommendations2026-10-18T01:38:36.132Z0.6https://business-news.org/ar/article/36663-2026-10-18T01:38:36.132Z0.5https://business-news.org/de/article/36663-zentrale-fur-krankheitenkontrolle-cdc-ladt-zum-kommentar-zu-einer-geplanten-datenverfolgun2026-10-18T01:38:36.132Z0.5https://business-news.org/es/article/36663-presentacion-de-una-recopilacion-de-datos-para-comentarios-y-recomendaciones-publicas2026-10-18T01:38:36.132Z0.5https://business-news.org/fr/article/36663-collecte-de-donnees-respiratoires-le-cdc-sollicite-des-commentaires-du-public2026-10-18T01:38:36.132Z0.5https://business-news.org/it/article/36663-proposta-di-raccolta-dati-sottoposta-a-commento-pubblico-e-raccomandazioni2026-10-18T01:38:36.132Z0.5https://business-news.org/ja/article/36663-cdc2026-10-18T01:38:36.132Z0.5https://business-news.org/ko/article/36663-cdc-19952026-10-18T01:38:36.132Z0.5https://business-news.org/nl/article/36663-geplande-gegevensverzameling-voor-open-commentaar-en-aanbevelingen-bij-de-centraal-bureau-2026-10-18T01:38:36.132Z0.5https://business-news.org/pl/article/36663-centra-do-kontrolowania-i-prevencji-chorob-cdc-zwroci-o-sie-do-publicznosci-i-innych-agenc2026-10-18T01:38:36.132Z0.5https://business-news.org/pt/article/36663-proposta-de-coleta-de-dados-submetida-a-comentario-publico-e-recomendacoes2026-10-18T01:38:36.132Z0.5https://business-news.org/ru/article/36663-2026-10-18T01:38:36.132Z0.5https://business-news.org/tr/article/36663-cdc-kamu-yonetimi-ve-government-bilgi-nin-faydas-n-maximize-etme-amac-yla-bir-veri-toplama2026-10-18T01:38:36.132Z0.5https://business-news.org/uk/article/36663-2026-10-18T01:38:36.132Z0.5https://business-news.org/zh/article/36663-cdc2026-10-18T01:38:36.132Z0.5https://business-news.org/article/36665-proposed-data-collection-submitted-for-public-comment-and-recommendations2026-10-18T01:38:00.535Z0.6https://business-news.org/ar/article/36665-2026-10-18T01:38:00.535Z0.5https://business-news.org/de/article/36665-zusammenlegung-von-daten-zur-offentlichen-kommentierung-und-empfehlung-eingereicht2026-10-18T01:38:00.535Z0.5https://business-news.org/es/article/36665-la-cdc-presenta-una-recopilacion-de-datos-para-comentarios-y-recomendaciones-publicas2026-10-18T01:38:00.535Z0.5https://business-news.org/fr/article/36665-collecte-de-donnees-proposee-a-la-commentaires-et-recommandations-du-public2026-10-18T01:38:00.535Z0.5https://business-news.org/it/article/36665-proposta-di-raccolta-dati-sottoposta-a-commento-pubblico-e-raccomandazioni2026-10-18T01:38:00.535Z0.5https://business-news.org/ja/article/36665-cdc2026-10-18T01:38:00.535Z0.5https://business-news.org/ko/article/36665-cdc2026-10-18T01:38:00.535Z0.5https://business-news.org/nl/article/36665-proposed-data-collection-submitted-voor-openbare-commentaar-en-advies2026-10-18T01:38:00.535Z0.5https://business-news.org/pl/article/36665-centra-kontrolowania-i-przeciwdzia-ania-chorob-cdc-zaprosi-ogo-spo-ecznosci-i-inne-agencje2026-10-18T01:38:00.535Z0.5https://business-news.org/pt/article/36665-proposta-de-coleta-de-dados-submetida-a-comentario-publico-e-recomendacoes2026-10-18T01:38:00.535Z0.5https://business-news.org/ru/article/36665-2026-10-18T01:38:00.535Z0.5https://business-news.org/tr/article/36665-cdc-kamu-ve-diger-federal-agencylar-n-participation-n-invitation-eden-1995-y-l-nda-paperwo2026-10-18T01:38:00.535Z0.5https://business-news.org/uk/article/36665-2026-10-18T01:38:00.535Z0.5https://business-news.org/zh/article/36665-cdc2026-10-18T01:38:00.535Z0.5https://business-news.org/article/36712-proposed-data-collection-submitted-for-public-comment-and-recommendations2026-10-19T08:33:27.504Z0.6https://business-news.org/ar/article/36712-2026-10-19T08:33:27.504Z0.5https://business-news.org/de/article/36712-zentrale-fur-krankheitenkontrolle-cdc-ladt-zum-kommentar-zu-einer-geplanten-datenverfolgun2026-10-19T08:33:27.504Z0.5https://business-news.org/es/article/36712-centros-para-el-control-y-prevencion-de-enfermedades-cdc-solicita-comentarios-sobre-una-re2026-10-19T08:33:27.504Z0.5https://business-news.org/fr/article/36712-collecte-de-donnees-sur-le-cancer-du-colon-cdc-demande-des-commentaires-et-recommandations2026-10-19T08:33:27.504Z0.5https://business-news.org/it/article/36712-cdc-invita-il-pubblico-a-commentare-sulla-raccolta-di-dati-per-il-controllo-del-cancro-del2026-10-19T08:33:27.504Z0.5https://business-news.org/ja/article/36712-2026-10-19T08:33:27.504Z0.5https://business-news.org/ko/article/36712-cdc-colorectal-cancer2026-10-19T08:33:27.504Z0.5https://business-news.org/nl/article/36712-cdc-vraagt-het-publiek-om-commentaar-op-een-geplande-gegevensverzameling2026-10-19T08:33:27.504Z0.5https://business-news.org/pl/article/36712-centra-do-kontrolowania-i-prevencji-chorob-cdc-zwroci-o-sie-do-publicznosci-i-innych-agenc2026-10-19T08:33:27.504Z0.5https://business-news.org/pt/article/36712-proposta-de-coleta-de-dados-submetida-a-comentario-publico-e-recomendacoes2026-10-19T08:33:27.504Z0.5https://business-news.org/ru/article/36712-2026-10-19T08:33:27.504Z0.5https://business-news.org/tr/article/36712-cdc-kamu-ve-diger-federal-ajanslar-icin-bir-kamu-commentu-f-rsat-sunuyor-kolon-kanser-kont2026-10-19T08:33:27.504Z0.5https://business-news.org/uk/article/36712-2026-10-19T08:33:27.504Z0.5https://business-news.org/zh/article/36712-cdc2026-10-19T08:33:27.504Z0.5https://business-news.org/article/36713-proposed-data-collection-submitted-for-public-comment-and-recommendations2026-10-18T09:50:03.010Z0.6https://business-news.org/ar/article/36713-2026-10-18T09:50:03.010Z0.5https://business-news.org/de/article/36713-zusammenlegung-von-daten-zur-offentlichen-kommentierung-und-empfehlung-eingereicht2026-10-18T09:50:03.010Z0.5https://business-news.org/es/article/36713-centros-para-el-control-y-prevencion-de-enfermedades-cdc-solicita-comentarios-sobre-una-re2026-10-18T09:50:03.010Z0.5https://business-news.org/fr/article/36713-collecte-de-donnees-proposee-a-la-consultation-publique-et-aux-recommandations2026-10-18T09:50:03.010Z0.5https://business-news.org/it/article/36713-cdc-invita-il-pubblico-a-commentare-sulla-raccolta-di-dati-proposta2026-10-18T09:50:03.010Z0.5https://business-news.org/ja/article/36713-cdc2026-10-18T09:50:03.010Z0.5https://business-news.org/ko/article/36713-cdc-19952026-10-18T09:50:03.010Z0.5https://business-news.org/nl/article/36713-cdc-maakt-een-voorstel-voor-gegevensverzameling-open-voor-commentaar-en-aanbevelingen2026-10-18T09:50:03.010Z0.5https://business-news.org/pl/article/36713-centra-kontrolowania-i-przeciwdzia-ania-chorob-cdc-zaprosi-ogo-spo-ecznosci-i-inne-agencje2026-10-18T09:50:03.010Z0.5https://business-news.org/pt/article/36713-proposta-de-coleta-de-dados-submetida-a-comentario-publico-e-recomendacoes2026-10-18T09:50:03.010Z0.5https://business-news.org/ru/article/36713-2026-10-18T09:50:03.010Z0.5https://business-news.org/tr/article/36713-cdc-kamu-ve-diger-federal-ajanslar-icin-kamu-yukunu-azaltmak-ve-hukumet-bilgiinin-maksimum2026-10-18T09:50:03.010Z0.5https://business-news.org/uk/article/36713-2026-10-18T09:50:03.010Z0.5https://business-news.org/zh/article/36713-cdc2026-10-18T09:50:03.010Z0.5https://business-news.org/article/36780-medical-devices-exemption-from-premarket-notification-radiology-computer-aided-detection-a2026-10-19T03:03:42.702Z0.6https://business-news.org/ar/article/36780-2026-10-19T03:03:42.702Z0.5https://business-news.org/de/article/36780-fda-entscheidet-uber-ausnahme-fur-medizinische-bildverstarker2026-10-19T03:03:42.702Z0.5https://business-news.org/es/article/36780-la-administracion-de-alimentos-y-medicamentos-fda-publica-un-orden-estableciendo-su-determ2026-10-19T03:03:42.702Z0.5https://business-news.org/fr/article/36780-exoneration-de-la-notification-pre-markete-pour-les-dispositifs-radiologiques-assistes-par2026-10-19T03:03:42.702Z0.5https://business-news.org/it/article/36780-fda-emancipa-dispositivi-radiologici-da-richiesta-di-prenotificazione-pre-mercato2026-10-19T03:03:42.702Z0.5https://business-news.org/ja/article/36780-2026-10-19T03:03:42.702Z0.5https://business-news.org/ko/article/36780-fda2026-10-19T03:03:42.702Z0.5https://business-news.org/nl/article/36780-fda-uitsluiting-voor-voorafgaande-melding-voor-medische-apparaten-voor-radiologie2026-10-19T03:03:42.702Z0.5https://business-news.org/pl/article/36780-fda-zalegalizowa-a-odmowe-zapytania-o-wyjatek-z-rekomendacji-przed-notyfikacja-w-sprawie-u2026-10-19T03:03:42.702Z0.5https://business-news.org/pt/article/36780-excecao-de-notificacao-pre-marketing-para-dispositivos-de-deteccao-e-diagnostico-de-radiol2026-10-19T03:03:42.702Z0.5https://business-news.org/ru/article/36780-2026-10-19T03:03:42.702Z0.5https://business-news.org/tr/article/36780-t-bbi-uygulamalar-onceden-bilgilendirme-talebi-oncelikten-kald-r-lmas-radyoloji-bilgisayar2026-10-19T03:03:42.702Z0.5https://business-news.org/uk/article/36780-2026-10-19T03:03:42.702Z0.5https://business-news.org/zh/article/36780-fda2026-10-19T03:03:42.702Z0.5https://business-news.org/article/36781-medicare-and-medicaid-programs-application-from-dnv-healthcare-usa-inc-dnv-for-continued-c2026-10-18T19:29:41.584Z0.6https://business-news.org/ar/article/36781-medicare-medicaid-dnv-healthcare-usa-inc-dnv-cms2026-10-18T19:29:41.584Z0.5https://business-news.org/de/article/36781-medizinsicherkeits-und-gesundheitsprogramme-antrag-von-dnv-healthcare-usa-inc-dnv-auf-fort2026-10-18T19:29:41.584Z0.5https://business-news.org/es/article/36781-aprobacion-de-dnv-healthcare-usa-inc-para-su-programa-de-acreditacion-de-hospitales-ante-c2026-10-18T19:29:41.584Z0.5https://business-news.org/fr/article/36781-cette-notice-reconnait-l-approbation-d-une-demande-de-dnv-healthcare-usa-inc-dnv-pour-le-m2026-10-18T19:29:41.584Z0.5https://business-news.org/it/article/36781-approvazione-della-dnv-healthcare-usa-inc-per-il-riconoscimento-nazionale-per-le-ospedali-2026-10-18T19:29:41.584Z0.5https://business-news.org/ja/article/36781-dnv-usainc-dnv-cms2026-10-18T19:29:41.584Z0.5https://business-news.org/ko/article/36781-dnv-cms-dnv-healthcare-usa-inc-dnv2026-10-18T19:29:41.584Z0.5https://business-news.org/nl/article/36781-medisynfoordeling-en-medisynprogramma-s-aanvraag-van-dnv-healthcare-usa-inc-dnv-voor-voort2026-10-18T19:29:41.584Z0.5https://business-news.org/pl/article/36781-medycyna-i-programy-medicare-i-medicaid-zg-oszenie-dnv-healthcare-usa-inc-dnv-o-utrzymanie2026-10-18T19:29:41.584Z0.5https://business-news.org/pt/article/36781-aprovacao-do-programa-de-acreditacao-hospitalar-da-dnv-healthcare-usa-inc-continuada-pela-2026-10-18T19:29:41.584Z0.5https://business-news.org/ru/article/36781-medicare-medicaid-dnv-healthcare-usa-inc-dnv-cms2026-10-18T19:29:41.584Z0.5https://business-news.org/tr/article/36781-medicare-ve-medicaid-programlar-dnv-sagl-k-hizmetleri-usa-inc-dnv-taraf-ndan-continuel-cms2026-10-18T19:29:41.584Z0.5https://business-news.org/uk/article/36781-medicare-medicaid-dnv-healthcare-usa-inc-dnv-cms2026-10-18T19:29:41.584Z0.5https://business-news.org/zh/article/36781-dnv-cms2026-10-18T19:29:41.584Z0.5https://business-news.org/article/36782-proposed-information-collection-activity-diaper-distribution-demonstration-and-research-pi2026-10-18T19:28:53.490Z0.6https://business-news.org/ar/article/36782-2026-10-18T19:28:53.490Z0.5https://business-news.org/de/article/36782-proposed-information-collection-activity-diaper-distribution-demonstration-und-forschungsp2026-10-18T19:28:53.490Z0.5https://business-news.org/es/article/36782-la-oficina-de-servicios-comunitarios-ocs-administracion-para-ninos-y-familias-acf-departam2026-10-18T19:28:53.490Z0.5https://business-news.org/fr/article/36782-activite-de-collecte-d-informations-proposee-par-l-office-des-services-communautaires-ocs-2026-10-18T19:28:53.490Z0.5https://business-news.org/it/article/36782-proposta-di-raccolta-dati-per-attivita-di-distribuzione-di-diseguali-e-dimostrazione-di-ri2026-10-18T19:28:53.490Z0.5https://business-news.org/ja/article/36782-2026-10-18T19:28:53.490Z0.5https://business-news.org/ko/article/36782-demonstration2026-10-18T19:28:53.490Z0.5https://business-news.org/nl/article/36782-proposed-dataverzameling-voor-diaperbehoeftedienst2026-10-18T19:28:53.490Z0.5https://business-news.org/pl/article/36782-propozycja-aktywnosci-zbiorczej-informacji-w-celu-zrozumienia-potrzeb-pochwy-i-wynikow-dla2026-10-18T19:28:53.490Z0.5https://business-news.org/pt/article/36782-proposta-de-coleta-de-dados-demonstracao-de-distribuicao-de-fraldas-e-pesquisa-piloto-enqu2026-10-18T19:28:53.490Z0.5https://business-news.org/ru/article/36782-2026-10-18T19:28:53.490Z0.5https://business-news.org/tr/article/36782-dislik-tuketimi-aktivitesinin-onerilen-veri-toplama-eylemi-dislik-dag-t-m-demostrasyonu-ve2026-10-18T19:28:53.490Z0.5https://business-news.org/uk/article/36782-2026-10-18T19:28:53.490Z0.5https://business-news.org/zh/article/36782-diaper2026-10-18T19:28:53.490Z0.5https://business-news.org/article/36783-medicare-program-medicare-appeals-adjustment-to-the-amount-in-controversy-threshold-amount2026-10-18T21:21:11.352Z0.6https://business-news.org/ar/article/36783-medicare-medicare-20272026-10-18T21:21:11.352Z0.5https://business-news.org/de/article/36783-anderung-der-schwellenwerte-fur-die-kontroverse-in-anspruch-aic-fur-das-jahr-20272026-10-18T21:21:11.352Z0.5https://business-news.org/es/article/36783-medicina-de-seguro-apelaciones-de-medicare-ajuste-de-los-limites-de-la-cantidad-en-controv2026-10-18T21:21:11.352Z0.5https://business-news.org/fr/article/36783-mise-a-jour-des-seuils-de-montant-en-litige-pour-les-audiences-devant-le-juge-administrati2026-10-18T21:21:11.352Z0.5https://business-news.org/it/article/36783-medicare-program-medici-programmi-aumento-dei-soggetti-soggetti-alla-controversia-per-l-an2026-10-18T21:21:11.352Z0.5https://business-news.org/ja/article/36783-20272026-10-18T21:21:11.352Z0.5https://business-news.org/ko/article/36783-2027-amount-in-controversy-aic-notice2026-10-18T21:21:11.352Z0.5https://business-news.org/nl/article/36783-medicijnenprogramma-appelemissies-aanpassing-van-de-grenswaarde-voor-de-bedrag-in-geschil-2026-10-18T21:21:11.352Z0.5https://business-news.org/pl/article/36783-zawiadomienie-o-zmianie-limity-w-sprawie-kontrowersji-w-ramach-programu-medicare-na-rok-202026-10-18T21:21:11.352Z0.5https://business-news.org/pt/article/36783-ajuste-do-limite-de-controversia-do-medicare-para-o-ano-calendario-20272026-10-18T21:21:11.352Z0.5https://business-news.org/ru/article/36783-20272026-10-18T21:21:11.352Z0.5https://business-news.org/tr/article/36783-medicare-program-medicare-appeals-2027-y-l-icin-kontroverse-miktar-duzenleme-tutar-degisik2026-10-18T21:21:11.352Z0.5https://business-news.org/uk/article/36783-20272026-10-18T21:21:11.352Z0.5https://business-news.org/zh/article/36783-20272026-10-18T21:21:11.352Z0.5https://business-news.org/article/36784-medicare-program-public-meeting-for-new-revisions-to-the-healthcare-common-procedure-codin2026-10-18T21:18:07.436Z0.6https://business-news.org/ar/article/36784-medicare-hcpcs-ii2026-10-18T21:18:07.436Z0.5https://business-news.org/de/article/36784-offentliche-sitzung-fur-neuausgaben-des-gesundheitsgemeinschaftsverfahrenskodierungs-syste2026-10-18T21:18:07.436Z0.5https://business-news.org/es/article/36784-reunion-publica-para-revisar-el-sistema-de-codigos-de-procedimientos-comunes-de-atencion-m2026-10-18T21:18:07.436Z0.5https://business-news.org/fr/article/36784-reunion-publique-pour-les-revisions-du-systeme-de-codification-des-procedures-communes-de-2026-10-18T21:18:07.436Z0.5https://business-news.org/it/article/36784-convegno-pubblico-per-revisioni-aggiornate-del-sistema-di-codifica-comune-per-procedure-sa2026-10-18T21:18:07.436Z0.5https://business-news.org/ja/article/36784-medicare-2026-healthcare-common-procedure-coding-system-hcpcs-level-ii2026-10-18T21:18:07.436Z0.5https://business-news.org/ko/article/36784-2026-2-hcpcs-22026-10-18T21:18:07.436Z0.5https://business-news.org/nl/article/36784-medicijnenprogramma-openbare-bijeenkomst-voor-nieuwe-revisies-van-het-healthcare-common-pr2026-10-18T21:18:07.436Z0.5https://business-news.org/pl/article/36784-spotkanie-publiczne-w-sprawie-nowych-zmian-w-systemie-kodowania-zadania-chirurgicznych-i-i2026-10-18T21:18:07.436Z0.5https://business-news.org/pt/article/36784-reuniao-publica-para-revisoes-do-sistema-de-codigos-de-procedimentos-comuns-de-saude-hcpcs2026-10-18T21:18:07.436Z0.5https://business-news.org/ru/article/36784-hcpcs-ii2026-10-18T21:18:07.436Z0.5https://business-news.org/tr/article/36784-saglik-imha-serifi-program-sagl-k-anlam-girisli-serifi-ii-dizisi-kodlama-sistemi-hcpcs-yuk2026-10-18T21:18:07.436Z0.5https://business-news.org/uk/article/36784-hcpcs-ii2026-10-18T21:18:07.436Z0.5https://business-news.org/zh/article/36784-hcpcs-ii-20262026-10-18T21:18:07.436Z0.5https://business-news.org/article/36786-opportunity-to-co-sponsor-events-with-the-office-of-research-integrity2026-10-18T21:55:32.253Z0.6https://business-news.org/ar/article/36786-2026-10-18T21:55:32.253Z0.5https://business-news.org/de/article/36786-moglichkeit-zur-mitfinanzierung-von-veranstaltungen-mit-dem-buro-fur-integritat-in-der-for2026-10-18T21:55:32.253Z0.5https://business-news.org/es/article/36786-oportunidad-de-co-sponsorizar-eventos-con-la-oficina-de-integridad-en-la-investigacion2026-10-18T21:55:32.253Z0.5https://business-news.org/fr/article/36786-opportunite-de-co-sponsoriser-des-evenements-avec-le-bureau-de-l-integrite-des-recherches2026-10-18T21:55:32.253Z0.5https://business-news.org/it/article/36786-opportunita-di-condividere-gli-eventi-con-l-ufficio-di-integrita-delle-ricerche2026-10-18T21:55:32.253Z0.5https://business-news.org/ja/article/36786-ori2026-10-18T21:55:32.253Z0.5https://business-news.org/ko/article/36786-office-of-research-integrity-ori-co-sponsorship-opportunity2026-10-18T21:55:32.253Z0.5https://business-news.org/nl/article/36786-mogelijkheid-om-evenementen-samen-te-sponsoren-met-het-kantoor-voor-onderzoeksgewidigde-in2026-10-18T21:55:32.253Z0.5https://business-news.org/pl/article/36786-mozliwosc-wspo-sponsorowania-wydarzen-z-biura-wspo-pracy-w-sprawach-naukowych2026-10-18T21:55:32.253Z0.5https://business-news.org/pt/article/36786-oportunidade-de-co-sponsorizar-eventos-com-a-oficina-de-integridade-no-ensino-de-pesquisa2026-10-18T21:55:32.253Z0.5https://business-news.org/ru/article/36786-2026-10-18T21:55:32.253Z0.5https://business-news.org/tr/article/36786-bilgi-gelistirme-ofisi-ile-etki-paylas-mlar-icin-f-rsat2026-10-18T21:55:32.253Z0.5https://business-news.org/uk/article/36786-2026-10-18T21:55:32.253Z0.5https://business-news.org/zh/article/36786-office-of-research-integrity2026-10-18T21:55:32.253Z0.5https://business-news.org/article/36787-government-owned-inventions-availability-for-licensing2026-10-18T21:16:23.393Z0.6https://business-news.org/ar/article/36787-2026-10-18T21:16:23.393Z0.5https://business-news.org/de/article/36787-regierungseigentum-verfugbarkeit-fur-lizenzierung2026-10-18T21:16:23.393Z0.5https://business-news.org/es/article/36787-inventos-del-gobierno-de-ee-uu-estan-disponibles-para-licencia2026-10-18T21:16:23.393Z0.5https://business-news.org/fr/article/36787-l-invention-gouvernementale-est-disponible-pour-un-licence2026-10-18T21:16:23.393Z0.5https://business-news.org/it/article/36787-invenzioni-di-proprieta-del-governo-disponibilita-per-la-licenza2026-10-18T21:16:23.393Z0.5https://business-news.org/ja/article/36787-2026-10-18T21:16:23.393Z0.5https://business-news.org/ko/article/36787-2026-10-18T21:16:23.393Z0.5https://business-news.org/nl/article/36787-overige-inrichtingen-van-de-verenigde-staten-bieden-inventedies-voor-licentie-aan2026-10-18T21:16:23.393Z0.5https://business-news.org/pl/article/36787-pomiar-instytutu-naukowy-allergii-i-infekcji-niaid-w-sprawie-dostepnosci-do-licencji2026-10-18T21:16:23.393Z0.5https://business-news.org/pt/article/36787-invencoes-governamentais-disponibilidade-de-licenciamento2026-10-18T21:16:23.393Z0.5https://business-news.org/ru/article/36787-2026-10-18T21:16:23.393Z0.5https://business-news.org/tr/article/36787-hukumet-mal-bulgu-lisanslama-olas-g2026-10-18T21:16:23.393Z0.5https://business-news.org/uk/article/36787-2026-10-18T21:16:23.393Z0.5https://business-news.org/zh/article/36787-2026-10-18T21:16:23.393Z0.5https://business-news.org/article/36791-agency-information-collection-request-30-day-public-comment-request2026-10-18T21:14:42.520Z0.6https://business-news.org/ar/article/36791-302026-10-18T21:14:42.520Z0.5https://business-news.org/de/article/36791-bundesbehorden-stellen-information-collection-request-an-die-offentlichkeit-zur-diskussion2026-10-18T21:14:42.520Z0.5https://business-news.org/es/article/36791-solicitud-de-recopilacion-de-informacion-de-la-agencia-peticion-de-comentarios-publicos-po2026-10-18T21:14:42.520Z0.5https://business-news.org/fr/article/36791-demande-de-collecte-d-informations-de-l-agence-demande-de-commentaires-publics-pendant-30-2026-10-18T21:14:42.520Z0.5https://business-news.org/it/article/36791-richiesta-di-raccolta-dati-dell-agenzia-richiesta-di-commenti-pubblici-per-30-giorni2026-10-18T21:14:42.520Z0.5https://business-news.org/ja/article/36791-1995-os-omb-icr-omb2026-10-18T21:14:42.520Z0.5https://business-news.org/ko/article/36791-302026-10-18T21:14:42.520Z0.5https://business-news.org/nl/article/36791-verzoek-tot-inzending-van-gegevens-bij-de-overheid-30-daags-open-commentaar2026-10-18T21:14:42.520Z0.5https://business-news.org/pl/article/36791-zg-oszenie-w-sprawie-zbioru-danych-przez-urzad-30-dniowy-termin-publicznej-dyskusji2026-10-18T21:14:42.520Z0.5https://business-news.org/pt/article/36791-agencia-solicita-coleta-de-informacoes-prazo-de-30-dias-para-comentarios-publicos2026-10-18T21:14:42.520Z0.5https://business-news.org/ru/article/36791-302026-10-18T21:14:42.520Z0.5https://business-news.org/tr/article/36791-sozlesmenin-ilgili-olas-degisikliklere-dair-30-gununer-iletisim-talebi2026-10-18T21:14:42.520Z0.5https://business-news.org/uk/article/36791-302026-10-18T21:14:42.520Z0.5https://business-news.org/zh/article/36791-office-302026-10-18T21:14:42.520Z0.5https://business-news.org/article/36792-order-under-sections-362-and-365-of-the-public-health-service-act-continuing-the-suspensio2026-10-18T21:13:41.047Z0.6https://business-news.org/ar/article/36792-362-3652026-10-18T21:13:41.047Z0.5https://business-news.org/de/article/36792-cdc-verlangert-quarantanebeschrankung2026-10-18T21:13:41.047Z0.5https://business-news.org/es/article/36792-el-centro-para-el-control-y-la-prevencion-de-enfermedades-cdc-continua-la-suspension-de-la2026-10-18T21:13:41.047Z0.5https://business-news.org/fr/article/36792-arrete-par-les-sections-362-et-365-du-service-de-sante-publique-des-etats-unis-le-droit-d-2026-10-18T21:13:41.047Z0.5https://business-news.org/it/article/36792-cdc-estende-la-sospensione-delle-entrate-da-paesi-dove-esiste-una-malattia-comunicabile-qu2026-10-18T21:13:41.047Z0.5https://business-news.org/ja/article/36792-362-3652026-10-18T21:13:41.047Z0.5https://business-news.org/ko/article/36792-cdc-2026-10-11-quarantineable-communicable-disease2026-10-18T21:13:41.047Z0.5https://business-news.org/nl/article/36792-cdc-verlengt-quarantiebeperking-voor-beperkte-personen-uit-landen-met-quarantinabeperkende2026-10-18T21:13:41.047Z0.5https://business-news.org/pl/article/36792-cdc-rozpowszeza-zatrzymanie-wprowadzania-okreslonych-osob-z-krajow-zakazonych-zakazeniem-z2026-10-18T21:13:41.047Z0.5https://business-news.org/pt/article/36792-centros-de-controle-e-prevencao-de-doencas-cdc-estende-suspensao-de-direito-de-entrada-de-2026-10-18T21:13:41.047Z0.5https://business-news.org/ru/article/36792-uspension2026-10-18T21:13:41.047Z0.5https://business-news.org/tr/article/36792-sozlesmeler-362-ve-365-te-yer-alan-halk-sagl-g-service-akt-n-n-durdurulmas-n-devam-etme-ka2026-10-18T21:13:41.047Z0.5https://business-news.org/uk/article/36792-362-3652026-10-18T21:13:41.047Z0.5https://business-news.org/zh/article/36792-362-3652026-10-18T21:13:41.047Z0.5https://business-news.org/article/36793-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-19T08:28:31.316Z0.6https://business-news.org/ar/article/36793-2026-10-19T08:28:31.316Z0.5https://business-news.org/de/article/36793-die-bundesbehorde-fur-lebensmittel-und-medikamente-fda-hat-eine-sammlung-von-informationen2026-10-19T08:28:31.316Z0.5https://business-news.org/es/article/36793-la-administracion-de-alimentos-y-medicamentos-fda-anuncia-la-presentacion-de-una-solicitud2026-10-19T08:28:31.316Z0.5https://business-news.org/fr/article/36793-collecte-d-informations-par-l-agence-de-la-securite-alimentaire-fda-soumission-a-la-revue-2026-10-19T08:28:31.316Z0.5https://business-news.org/it/article/36793-l-agente-per-la-sicurezza-alimentare-fda-annuncia-la-presentazione-di-una-proposta-di-racc2026-10-19T08:28:31.316Z0.5https://business-news.org/ja/article/36793-office-of-management-and-budget-omb-office-of-management-and-budget-agency2026-10-19T08:28:31.316Z0.5https://business-news.org/ko/article/36793-fda-omb-2024-1-222026-10-19T08:28:31.316Z0.5https://business-news.org/nl/article/36793-fda-maakt-bekend-dat-het-een-verzameling-gegevens-van-informatie-heeft-ingediend-voor-revi2026-10-19T08:28:31.316Z0.5https://business-news.org/pl/article/36793-biological-products-zbior-danych-w-sprawie-lekow-biologicznych-i-wywo-ania-opinii-w-sprawi2026-10-19T08:28:31.316Z0.5https://business-news.org/pt/article/36793-a-agencia-de-alimentos-e-medicamentos-fda-anuncia-a-apresentacao-de-uma-coleta-de-informac2026-10-19T08:28:31.316Z0.5https://business-news.org/ru/article/36793-2026-10-19T08:28:31.316Z0.5https://business-news.org/tr/article/36793-biyolojik-urunler-ve-hucre-tissue-ve-hucre-tabanl-urunlerde-degisikliklerin-raporlanmas-ve2026-10-19T08:28:31.316Z0.5https://business-news.org/uk/article/36793-2026-10-19T08:28:31.316Z0.5https://business-news.org/zh/article/36793-fda-omb2026-10-19T08:28:31.316Z0.5https://business-news.org/article/36794-proposed-collection-60-day-comment-request-nih-intramural-reporting-of-research-misconduct2026-10-18T21:11:14.540Z0.6https://business-news.org/ar/article/36794-60-irrm2026-10-18T21:11:14.540Z0.5https://business-news.org/de/article/36794-nih-plantet-ein-neues-web-formular-fur-meldung-von-forschungsunregelma-igkeiten-ein-60-tag2026-10-18T21:11:14.540Z0.5https://business-news.org/es/article/36794-nih-solicita-comentarios-sobre-nuevo-formulario-web-para-informar-irregularidades-en-inves2026-10-18T21:11:14.540Z0.5https://business-news.org/fr/article/36794-demande-de-commentaires-sur-un-formulaire-de-declaration-de-la-non-conformite-aux-normes-d2026-10-18T21:11:14.540Z0.5https://business-news.org/it/article/36794-proposta-di-raccolta-richiesta-di-commento-per-60-giorni-modulo-web-per-il-rapporto-sulla-2026-10-18T21:11:14.540Z0.5https://business-news.org/ja/article/36794-nih-irrm-602026-10-18T21:11:14.540Z0.5https://business-news.org/ko/article/36794-nih-42-cfr-93-forms-60-nih-intramural-research-program2026-10-18T21:11:14.540Z0.5https://business-news.org/nl/article/36794-nih-vraagt-60-dagen-comment-over-nieuwe-webform-voor-misbruik-van-onderzoeksmethoden2026-10-18T21:11:14.540Z0.5https://business-news.org/pl/article/36794-nih-zapytanie-o-opinie-na-nowy-formularz-raportowania-niehonorowosci-w-badaniach-wewnetrzn2026-10-18T21:11:14.540Z0.5https://business-news.org/pt/article/36794-nih-solicita-comentarios-sobre-proposta-de-formulario-para-relatorios-de-irregularidades-d2026-10-18T21:11:14.540Z0.5https://business-news.org/ru/article/36794-60-irrm2026-10-18T21:11:14.540Z0.5https://business-news.org/tr/article/36794-nih-ic-irtibat-arast-rmalar-uygulamas-icin-raporlama-formu-onerisi-60-gun-iletisim-talebi2026-10-18T21:11:14.540Z0.5https://business-news.org/uk/article/36794-60-nih-irrm2026-10-18T21:11:14.540Z0.5https://business-news.org/zh/article/36794-nih-602026-10-18T21:11:14.540Z0.5https://business-news.org/article/36795-microbiology-devices-panel-of-the-medical-devices-advisory-committee-notice-of-meeting-est2026-10-18T21:11:16.014Z0.6https://business-news.org/ar/article/36795-2026-10-18T21:11:16.014Z0.5https://business-news.org/de/article/36795-fda-innenbeirat-fur-mikrobiologiegerate-offentliche-anhorung-zum-pathogen-agnostischen-seq2026-10-18T21:11:16.014Z0.5https://business-news.org/es/article/36795-el-comite-asesor-de-dispositivos-medicos-de-la-comision-asesorada-de-productos-medicos-de-2026-10-18T21:11:16.014Z0.5https://business-news.org/fr/article/36795-rendez-vous-du-comite-d-avis-medical-sur-les-dispositifs-microbiologiques-une-reunion-publ2026-10-18T21:11:16.014Z0.5https://business-news.org/it/article/36795-il-comitato-consulente-per-i-dispositivi-microbiologici-della-commissione-consulente-per-i2026-10-18T21:11:16.014Z0.5https://business-news.org/ja/article/36795-fda2026-10-18T21:11:16.014Z0.5https://business-news.org/ko/article/36795-2026-10-18T21:11:16.014Z0.5https://business-news.org/nl/article/36795-fda-stelt-microbiologieapparatenraad-bij-om-pathogen-afhankelijke-sequencing-te-bespreken2026-10-18T21:11:16.014Z0.5https://business-news.org/pl/article/36795-rady-biologicznych-urzadzen-leczniczych-komitetu-doradcow-produktow-medycznych-fda2026-10-18T21:11:16.014Z0.5https://business-news.org/pt/article/36795-comite-de-dispositivos-microbiologicos-da-comissao-consultiva-de-produtos-medicos-da-fda-n2026-10-18T21:11:16.014Z0.5https://business-news.org/ru/article/36795-2026-10-18T21:11:16.014Z0.5https://business-news.org/tr/article/36795-biyolojik-cihazlar-dan-sma-komitesi-nin-t-bbi-cihazlar-dan-sma-komitesi-ne-ait-bir-ozetlem2026-10-18T21:11:16.014Z0.5https://business-news.org/uk/article/36795-2026-10-18T21:11:16.014Z0.5https://business-news.org/zh/article/36795-2026-10-18T21:11:16.014Z0.5https://business-news.org/article/36796-world-trade-center-health-program-petition-048a-peripheral-artery-disease-finding-of-insuf2026-10-19T08:37:46.809Z0.6https://business-news.org/ar/article/36796-048a2026-10-19T08:37:46.809Z0.5https://business-news.org/de/article/36796-wtc-gesundheitsprogramm-keine-ausreichenden-beweise-fur-peripheren-arterienkranz2026-10-19T08:37:46.809Z0.5https://business-news.org/es/article/36796-el-administrador-del-programa-de-salud-del-world-trade-center-rechaza-la-solicitud-de-agre2026-10-19T08:37:46.809Z0.5https://business-news.org/fr/article/36796-le-programme-de-sante-du-world-trade-center-rejette-la-demande-de-considerer-la-maladie-de2026-10-19T08:37:46.809Z0.5https://business-news.org/it/article/36796-il-programma-di-salute-del-world-trade-center-rifiuta-di-aggiungere-la-malattia-delle-arte2026-10-19T08:37:46.809Z0.5https://business-news.org/ja/article/36796-048a2026-10-19T08:37:46.809Z0.5https://business-news.org/ko/article/36796-048a2026-10-19T08:37:46.809Z0.5https://business-news.org/nl/article/36796-wtc-gezondheidsprogramma-geen-bewijs-voor-perifere-arterieziekte2026-10-19T08:37:46.809Z0.5https://business-news.org/pl/article/36796-program-wielkopolskiego-centrum-handlu-swiatowego-brak-dowodow-na-chorobe-naczyniowa-wez-o2026-10-19T08:37:46.809Z0.5https://business-news.org/pt/article/36796-programa-de-saude-do-world-trade-center-peticao-048a-doenca-das-arterias-perifericas-encon2026-10-19T08:37:46.809Z0.5https://business-news.org/ru/article/36796-2026-10-19T08:37:46.809Z0.5https://business-news.org/tr/article/36796-world-trade-center-health-program-petition-048a-peripheral-artery-disease-bulunamayan-evid2026-10-19T08:37:46.809Z0.5https://business-news.org/uk/article/36796-2026-10-19T08:37:46.809Z0.5https://business-news.org/zh/article/36796-petition-048a2026-10-19T08:37:46.809Z0.5https://business-news.org/article/36797-world-trade-center-health-program-petitions-048-and-051a-stroke-finding-of-insufficient-ev2026-10-19T08:58:16.824Z0.6https://business-news.org/ar/article/36797-048-051a2026-10-19T08:58:16.824Z0.5https://business-news.org/de/article/36797-wtc-gesundheitsprogramm-keine-ausreichenden-beweise-fur-die-einfuhrung-von-schlaganfallen2026-10-19T08:58:16.824Z0.5https://business-news.org/es/article/36797-el-administrador-del-programa-de-salud-del-world-trade-center-rechaza-las-peticiones-para-2026-10-19T08:58:16.824Z0.5https://business-news.org/fr/article/36797-le-programme-de-sante-du-world-trade-center-absence-de-preuve-suffisante-pour-inclure-les-2026-10-19T08:58:16.824Z0.5https://business-news.org/it/article/36797-il-programma-di-salute-del-world-trade-center-non-trova-prove-sufficienti-per-aggiungere-l2026-10-19T08:58:16.824Z0.5https://business-news.org/ja/article/36797-048-051a2026-10-19T08:58:16.824Z0.5https://business-news.org/ko/article/36797-048-051a-stroke2026-10-19T08:58:16.824Z0.5https://business-news.org/nl/article/36797-wtc-gezondheidsprogramma-geen-bewijs-voor-stroke2026-10-19T08:58:16.824Z0.5https://business-news.org/pl/article/36797-program-wielkiej-kolumny-zdrowia-nie-ma-wystarczajacych-dowodow-na-zwiazek-z-udarem2026-10-19T08:58:16.824Z0.5https://business-news.org/pt/article/36797-programa-de-saude-do-world-trade-center-peticoes-048-e-051a-infarto-conclusao-de-evidencia2026-10-19T08:58:16.824Z0.5https://business-news.org/ru/article/36797-048-0512026-10-19T08:58:16.824Z0.5https://business-news.org/tr/article/36797-world-trade-center-sagl-k-program-sagl-k-kosuluyla-wtc-ile-ilgili-sagl-k-problemleri-liste2026-10-19T08:58:16.824Z0.5https://business-news.org/uk/article/36797-world-trade-center-048-0512026-10-19T08:58:16.824Z0.5https://business-news.org/zh/article/36797-petition-048-051a2026-10-19T08:58:16.824Z0.5https://business-news.org/article/36798-prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-engi2026-10-18T23:54:53.903Z0.6https://business-news.org/ar/article/36798-hpv-16-e62026-10-18T23:54:53.903Z0.5https://business-news.org/de/article/36798-medgene-therapeutics-erhalt-moglicherweise-exklusive-lizenz-fur-die-verwendung-von-patentr2026-10-18T23:54:53.903Z0.5https://business-news.org/es/article/36798-concesion-de-una-licencia-exclusiva-de-un-brevet-para-el-desarrollo-y-comercializacion-de-2026-10-18T23:54:53.903Z0.5https://business-news.org/fr/article/36798-attribution-d-une-licence-exclusive-de-brevet-pour-le-developpement-et-la-commercialisatio2026-10-18T23:54:53.903Z0.5https://business-news.org/it/article/36798-concessione-di-un-patento-esclusivo-di-licenza-sviluppo-e-commercializzazione-di-terapie-c2026-10-18T23:54:53.903Z0.5https://business-news.org/ja/article/36798-hpv-16-e62026-10-18T23:54:53.903Z0.5https://business-news.org/ko/article/36798-hpv-16-e6-expressing-cancers-engineered-cell-therap-exclusiv-patent-license2026-10-18T23:54:53.903Z0.5https://business-news.org/nl/article/36798-uwzonderlijke-patentlicentie-voor-medische-cellentherapie-voor-hpv-16-cancerbehandeling2026-10-18T23:54:53.903Z0.5https://business-news.org/pl/article/36798-zainteresowanie-grantem-wy-acznej-licencji-patentu-przez-instytut-kanceru-narodowego2026-10-18T23:54:53.903Z0.5https://business-news.org/pt/article/36798-aprovagem-prospectiva-de-uma-licenca-exclusiva-de-patente-desenvolvimento-e-comercializaca2026-10-18T23:54:53.903Z0.5https://business-news.org/ru/article/36798-hpv-16-e62026-10-18T23:54:53.903Z0.5https://business-news.org/tr/article/36798-ulusal-kanser-enstitusu-ulusal-sagl-k-ve-gelisme-bakanl-g-n-n-bir-subesi-olan-ulusal-sagl-2026-10-18T23:54:53.903Z0.5https://business-news.org/uk/article/36798-hpv-16-e62026-10-18T23:54:53.903Z0.5https://business-news.org/zh/article/36798-2026-10-18T23:54:53.903Z0.5